You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Management of Neuropsychiatric Symptoms

Percentage of patients, regardless of age, with a diagnosis of dementia who have one or more neuropsychiatric symptoms who received or were recommended to receive an intervention for neuropsychiatric symptoms within a 12 month period

Date Reviewed: November 19, 2017

Measure Info

MIPS 284CMS 284
Measure Type: 
Measure Steward: 
American Academy of Neurology
Clinical Topic Area: 

Care Setting: 
Data Source: 

ACP does not support QPP measure 284" "Dementia: Management of Neuropsychiatric Symptoms." Although this practice may help clinicians determine appropriate management of patients with dementia, there is a lack of high-quality evidence examining the impact of assessment on clinical outcomes or on appropriate assessment intervals. Also, implementation may result in overuse of pharmacologic therapy. Non- pharmacologic treatment modalities exist to manage neuropsychiatric symptoms, but implementation requires caregiver involvement. Furthermore, the numerator details do not specify a structured process for documentation of neuropsychiatric symptom assessment and the measure developers do not include reliability or validity data in the measure report.